Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Milestone Pharmaceuticals (MIST) Common Equity: 2021

Historic Common Equity for Milestone Pharmaceuticals (MIST) over the last 1 years, with Dec 2021 value amounting to $112.6 million.

  • Milestone Pharmaceuticals' Common Equity fell 39.45% to $77.2 million in Q3 2022 from the same period last year, while for Sep 2022 it was $77.2 million, marking a year-over-year decrease of 39.45%. This contributed to the annual value of $112.6 million for FY2021, which is N/A change from last year.
  • Latest data reveals that Milestone Pharmaceuticals reported Common Equity of $112.6 million as of FY2021.
  • In the past 5 years, Milestone Pharmaceuticals' Common Equity registered a high of $112.6 million during FY2021, and its lowest value of $112.6 million during FY2021.
  • Over the past 1 years, Milestone Pharmaceuticals' median Common Equity value was $112.6 million (recorded in 2021), while the average stood at $112.6 million.